Trial Profile
Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2014
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary) ; Fondaparinux sodium
- Indications Thromboembolism
- Focus Therapeutic Use
- 10 Sep 2014 New trial record